Center-Authored Papers

Filters: Author is Woolfrey, Ann E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano J-A, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S et al..  2014.  Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(12):1996-2003. Abstract
Thakar MS, Kurre P, Storb R, Kletzel M, Frangoul H, Pulsipher MA, Leisenring WM, Flowers MED, Sandmaier BM, Woolfrey AE et al..  2011.  Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.. Bone marrow transplantation. 46(4):539-44. Abstract
Bitan M, He W, Zhang M-J, Abdel-Azim H, Ayas MF, Bielorai B, Carpenter PA, Cairo MS, Diaz MA, Horan JT et al..  2014.  Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.. Blood. Abstract
Sanders JE, Hoffmeister PA, Woolfrey AE, Carpenter PA, Storer BE, Storb R, Appelbaum FR.  2009.  Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.. Blood. 113(2):306-8. Abstract
S
Burroughs LM, Woolfrey AE, Storer BE, Deeg HJ, Flowers MED, Martin PJ, Carpenter PA, Doney K, Appelbaum FR, Sanders JE et al..  2012.  Success of allogeneic marrow transplantation for children with severe aplastic anaemia.. British journal of haematology. 158(1):120-8. Abstract
Burroughs LM, Torgerson TR, Storb R, Carpenter PA, Rawlings DJ, Sanders JE, Scharenberg AM, Skoda-Smith S, Englund J, Ochs HD et al..  2010.  Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.. The Journal of allergy and clinical immunology. 126(5):1000-5. Abstract
Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn J-Y, Cervantes F, Copelan E et al..  2009.  Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(11):1475-8. Abstract
Burroughs LM, Woolfrey AE, Shimamura A.  2009.  Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment.. Hematology/oncology clinics of North America. 23(2):233-48. Abstract
Scott A, Glover J, Skoda-Smith S, Torgerson TR, Xu M, Burroughs LM, Woolfrey AE, Fleming MD, Shimamura A.  2015.  Severe combined immunodeficiency (SCID) presenting with neonatal aplastic anemia.. Pediatric blood & cancer. Abstract
R
Peterson CW, Younan P, Polacino PS, Maurice NJ, Miller HW, Prlic M, Jerome KR, Woolfrey AE, Hu S-lok, Kiem H-P.  2013.  Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection.. Journal of medical primatology. 42(5):237-46. Abstract
Brunstein CG, Eapen M, Woo Ahn K, Appelbaum FR, Ballen KK, Champlin RE, Cutler C, Kan F, Laughlin MJ, Soiffer RJ et al..  2012.  Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.. Blood. 119(23):5591-8. Abstract
Kornblit B, Maloney DG, Storer BE, Maris MB, Vindeløv L, Hari P, Langston AA, Pulsipher MA, Bethge WA, Chauncey TR et al..  2014.  A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after nonmyeloablative unrelated donor transplantation.. Haematologica. 99(10):1624-31. Abstract
P
Gutman JA, McKinney SK, Pereira S, Warnock SL, Smith AG, Woolfrey AE, Hansen JA, Delaney C.  2009.  Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies.. Transplantation. 87(3):415-8. Abstract
Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A et al..  2012.  Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.. Bone marrow transplantation. 47(6):810-816. Abstract
Guinan E, Luzmik L, Handgretinger R, Woolfrey AE.  2010.  Preservation of immune repertoire by selective depletion of haploidentical grafts.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(1 Suppl):S68-74. Abstract
Seftel MD, Neuberg D, Zhang M-J, Wang H-L, Ballen KK, Bergeron J, Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA et al..  2016.  Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.. American journal of hematology. 91(3):322-329. Abstract
O
Aspesberro F, Guthrie KA, Woolfrey AE, Brogan TV, Roberts JS.  2014.  Outcome of pediatric hematopoietic stem cell transplant recipients requiring mechanical ventilation.. Journal of intensive care medicine. 29(1):31-7. Abstract
Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo MS, Dvorak C, Duval M, Davies S et al..  2011.  Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(12):1833-40. Abstract
N
Adair JE, Chandrasekaran D, Sghia-Hughes G, Haworth KG, Woolfrey AE, Burroughs LM, Choi GY, Becker PS, Kiem H-P.  2018.  Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A.. Haematologica. Abstract
Ram R, Storb R, Sandmaier BM, Maloney DG, Woolfrey AE, Flowers MED, Maris MB, Laport GG, Chauncey TR, Lange T et al..  2011.  Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.. Haematologica. 96(8):1113-20. Abstract
L
Nakamae H, Storer BE, Storb R, Storek J, Chauncey TR, Pulsipher MA, Petersen FB, Wade JC, Maris MB, Bruno B et al..  2010.  Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(3):384-94. Abstract
Gutman JA, Leisenring WM, Appelbaum FR, Woolfrey AE, Delaney C.  2009.  Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(9):1122-9. Abstract
Peterson CW, Benne C, Polacino P, Kaur J, McAllister CE, Filali-Mouhim A, Obenza W, Pecor TA, Huang M-L, Baldessari A et al..  2017.  Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation.. JCI insight. 2(4):e91230. Abstract
Woolfrey AE, Storek J, Bowyer S, Nelson R, Robertson M, Wallace C.  2010.  Long-term response of juvenile idiopathic arthritis after conditioning with 8 Gy total body irradiation followed by autologous peripheral blood stem cells: case report.. Pediatric transplantation. 14(6):E65-9. Abstract
Sanders JE, Woolfrey AE, Carpenter PA, Storer BE, Hoffmeister PA, Deeg HJ, Flowers MED, Storb R.  2011.  Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.. Blood. 118(5):1421-8. Abstract